Asier García Alija

Clinical Trial Sub-Investigator (D3463C00002): Phase IB, double-blind, randomized, placebo-controlled, multicenter study to evaluate the safety, tolerability, and pharmacokinetics of multiple ascending doses of RO7303509 in patients with systemic sclerosis.

VAR-EPIDSER Project: Screening criteria for diffuse interstitial lung disease in rheumatoid arthritis - Validity study, 2024. Multicenter study to evaluate the applicability and representativeness of these criteria.

Digital Rheumatology – Integration of Process Mining and Language Models. A 12-month program at Hospital de Sant Pau to develop a project that analyzes structured and unstructured data from patients with Rheumatoid Arthritis, identifies critical points in the clinical pathway, reduces diagnosis and treatment times, and promotes personalized medicine.

Development of an AI-assisted Virtual Care Control Room in the Rheumatology Department of the University Hospital of Lausanne (CHUV) to improve telemonitoring and digital health.

Clinical Trial Sub-Investigator (FYU-981-CRYS-301): Multicenter, double-blind, randomized, phase 3 study to evaluate the efficacy and safety of dotinurad compared to allopurinol in adult participants with gout-associated hyperuricemia.

Implementation of a virtual “care” room in Rheumatology that integrates digital health technologies (mobile applications, digital biomarkers) and artificial intelligence algorithms for remote monitoring of patients with arthritis.

Clinical trial to evaluate the efficacy of dotinurad in reducing serum uric acid at week 24 compared to allopurinol in adult participants with gout-associated hyperuricemia.